Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT – Get Free Report) was the recipient of a large drop in short interest during the month of September. As of September 15th, there was short interest totaling 24 shares, a drop of 89.9% from the August 31st total of 238 shares. Approximately 0.0% of the shares of the company are short sold. Based on an average daily volume of 3,504 shares, the days-to-cover ratio is currently 0.0 days.
Institutional Investors Weigh In On Innovator IBD Breakout Opportunities ETF
A hedge fund recently raised its stake in Innovator IBD Breakout Opportunities ETF stock. Comprehensive Wealth Management LLC grew its position in Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT – Free Report) by 122.0% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 23,403 shares of the company’s stock after purchasing an additional 12,859 shares during the period. Comprehensive Wealth Management LLC owned approximately 6.69% of Innovator IBD Breakout Opportunities ETF worth $850,000 at the end of the most recent quarter.
Innovator IBD Breakout Opportunities ETF Price Performance
NYSEARCA:BOUT traded up $0.16 during trading hours on Friday, hitting $43.50. 218 shares of the company were exchanged, compared to its average volume of 3,664. The stock has a market capitalization of $15.22 million, a price-to-earnings ratio of 28.69 and a beta of 1.02. Innovator IBD Breakout Opportunities ETF has a 52-week low of $35.05 and a 52-week high of $49.41. The company’s 50 day moving average price is $44.96 and its 200-day moving average price is $44.61.
About Innovator IBD Breakout Opportunities ETF
The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is managed by Innovator.
Recommended Stories
- Five stocks we like better than Innovator IBD Breakout Opportunities ETF
- Costco Ends Its Fiscal Year on a High Note, Eyes Big Expansion
- Cracker Barrel Stock Is Rallying Again, But the Turnaround Still Has a Traffic Problem
- Oracle’s Force Majeure Notice Exposes a Bigger Problem for the AI Build-Out
- Oil May Be Stronger Than It Looks—And Diamondback Is on Sale
Receive News & Ratings for Innovator IBD Breakout Opportunities ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovator IBD Breakout Opportunities ETF and related companies with MarketBeat.com's FREE daily email newsletter.
